What is the primary function of FDG in a PET scan?

What is the primary function of FDG in a PET scan?

• A. To detect structural abnormalities
• B. To measure blood oxygen levels
• C. To visualize glucose metabolism in tissues
• D. To analyze the lymphatic system

Answer: (C)

In a PET scan, the primary function of FDG, or fluorodeoxyglucose, is to visualize glucose metabolism in tissues. FDG is a radiotracer that mimics glucose; when administered, it is taken up by cells in the body where there is increased glucose metabolism. This is particularly relevant in oncology, as cancer cells often have higher metabolic rates compared to normal tissues. By detecting the concentration of FDG in different areas of the body, PET scans can provide valuable insights into metabolic activity, helping to identify tumor locations, assess tumor response to therapy, and monitor disease progression. This ability to visualize metabolic processes is a key aspect that distinguishes PET scans from traditional imaging methods, which primarily focus on structural information rather than functional activity. In this context, the first option of detecting structural abnormalities is more aligned with techniques like CT or MRI rather than PET, which is metabolically focused. Similarly, measuring blood oxygen levels is typically outside the scope of what PET imaging directly assesses; instead, it provides indirect insights through metabolic activity. Analyzing the lymphatic system is also not a primary function of FDG in PET scans, as FDG is not specifically designed to visualize lymphatic flow or structure. Thus, understanding the role of

In a PET scan, the primary function of FDG, or fluorodeoxyglucose, is to visualize glucose metabolism in tissues. FDG is a radiotracer that mimics glucose; when administered, it is taken up by cells in the body where there is increased glucose metabolism. This is particularly relevant in oncology, as cancer cells often have higher metabolic rates compared to normal tissues.

By detecting the concentration of FDG in different areas of the body, PET scans can provide valuable insights into metabolic activity, helping to identify tumor locations, assess tumor response to therapy, and monitor disease progression. This ability to visualize metabolic processes is a key aspect that distinguishes PET scans from traditional imaging methods, which primarily focus on structural information rather than functional activity.

In this context, the first option of detecting structural abnormalities is more aligned with techniques like CT or MRI rather than PET, which is metabolically focused. Similarly, measuring blood oxygen levels is typically outside the scope of what PET imaging directly assesses; instead, it provides indirect insights through metabolic activity. Analyzing the lymphatic system is also not a primary function of FDG in PET scans, as FDG is not specifically designed to visualize lymphatic flow or structure. Thus, understanding the role of